Difficulty: Medium
Average Score: 90%
Practice
What is the advantage of levodopa over dopamine in treating parkinsonism?
Correct answer
A
Rationale
Rationale:
Levodopa is preferred over dopamine in treating parkinsonism due to several advantages. The correct answer, "It is more stable," is right because levodopa can cross the blood-brain barrier and convert into dopamine in the brain, providing a steady and sustained supply of dopamine, which is crucial for managing the symptoms of Parkinson's disease.
Option B, "It is less toxic," is not the best choice because levodopa can indeed cause side effects such as dyskinesias and motor fluctuations with long-term use. However, dopamine itself is highly reactive and cannot be administered directly as it would be rapidly metabolized in the peripheral circulation, leading to systemic side effects.
Option C, "It is more readily available," is not the most accurate choice as dopamine is a neurotransmitter that cannot be administered directly due to its instability. Levodopa, being a precursor to dopamine, is the more feasible option for therapeutic use in Parkinson's disease.
Educationally, understanding the rationale behind choosing levodopa over dopamine in treating parkinsonism is crucial for healthcare professionals to make informed decisions when managing patients with this condition. This knowledge helps in optimizing treatment outcomes while minimizing side effects and complications associated with therapy. It also underscores the importance of drug pharmacology and its application in clinical practice for effective patient care.
Levodopa is preferred over dopamine in treating parkinsonism due to several advantages. The correct answer, "It is more stable," is right because levodopa can cross the blood-brain barrier and convert into dopamine in the brain, providing a steady and sustained supply of dopamine, which is crucial for managing the symptoms of Parkinson's disease.
Option B, "It is less toxic," is not the best choice because levodopa can indeed cause side effects such as dyskinesias and motor fluctuations with long-term use. However, dopamine itself is highly reactive and cannot be administered directly as it would be rapidly metabolized in the peripheral circulation, leading to systemic side effects.
Option C, "It is more readily available," is not the most accurate choice as dopamine is a neurotransmitter that cannot be administered directly due to its instability. Levodopa, being a precursor to dopamine, is the more feasible option for therapeutic use in Parkinson's disease.
Educationally, understanding the rationale behind choosing levodopa over dopamine in treating parkinsonism is crucial for healthcare professionals to make informed decisions when managing patients with this condition. This knowledge helps in optimizing treatment outcomes while minimizing side effects and complications associated with therapy. It also underscores the importance of drug pharmacology and its application in clinical practice for effective patient care.